TBA (last known deadline was September 9, 2011)
JDRF is soliciting expressions of interest (EOI) for the study of modifications of beta cell antigens in the immunopathogenesis and treatment of type 1 diabetes (T1D). JDRF is committed and most interested in investigator-initiated proposals that focus on research that will translate to clinical results.